Skip to main content

Table 3 The overall response rate and median survival between limited stage PD-L1 positive and negative groups

From: Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience

  Limited stage disease P value
PD-L1 positive PD-L1 negative
(n = 6) (n = 5)
Male sex (%) 4 (66%) 2 (40%)  
Received treatment 6 (100%) 5 (100%)  
Response rates to treatment 6 (100%) 5 (100%)  
Alive at 1 year 6 (100%) 4 (80%)  
Median overall survival (mo.) 53 15 0.80